Fatigue
Disease2 papersMeSH D005221
- Human trial1
Trial sponsors
New York State Psychiatric Institute
2 trialsPhase 4102 people
University of Lausanne Hospitals
1 trialPhase 4154 people
Federal University of Juiz de Fora
1 trialPhase 4110 people
Wake Forest University Health Sciences
3 trialsPhase 3298 people
Eastern Cooperative Oncology Group
1 trialPhase 3282 people
1 trialPhase 3230 people
1 trialPhase 3121 people
ETOP IBCSG Partners Foundation
1 trialPhase 386 people
Funding
National Cancer InstituteUS$1.1mNational Institute on AgingUS$124.2k4 grants since 2023
National Cancer InstituteUniversity of Maryland BaltimoreUS$638.5k2026–2031
National Cancer InstituteUniversity of Maryland BaltimoreUS$363.6k2024–2028
National Institute on AgingUniversity of Maryland BaltimoreUS$124.2k2023–2028
National Cancer InstituteUniversity of RochesterUS$133.5k2026–2028
Latest
83Microbial compounds limited muscle loss in aged mice
In a 10-day experiment, two compounds improved different aspects of muscle function in aged male and female mice with one hindlimb immobilised.In a 10-day experiment, two compounds improved different aspects of muscle function in aged male and female mice with one hindlimb immobilised.
Fluvoxamine may ease fatigue in adults with long COVID
Mean Fatigue Severity Scale scores were 0.43 points lower than placebo at day 60 and 0.58 points lower at day 90.Mean Fatigue Severity Scale scores were 0.43 points lower than placebo at day 60 and 0.58 points lower at day 90.